Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles for Hospitalized Patients with Moderate-to-Severe ARDS: A Phase III Clinical Trial
Clinical Trial Grant
Administered By
Trauma, Acute, and Critical Care Surgery
Awarded By
Direct Biologics LLC
Start Date
October 14, 2023
End Date
September 30, 2028
Administered By
Trauma, Acute, and Critical Care Surgery
Awarded By
Direct Biologics LLC
Start Date
October 14, 2023
End Date
September 30, 2028